Environmental assessment and durability performance of cement mortar incorporating sugarcane vinasse in replacement of water.

Sugarcane vinasse wastewater (SVW) is one of the most voluminous waste generated in the ethanol industry and usually applied in fertigation. It is characterized by presenting high COD and BOD; thus, continued disposal of vinasse results in negative environmental impacts. In this paper, we investigated the potential of SVW in replacement of water in mortar, rethinking about reuse of effluent, reduction of pollutants in the environment, and water consumption in civil construction. Mortar composites with 0, 20, 40, 60, 80, and 100% of water replaced by SVW were studied in order to determine the optimum content. Mortars with 60 to 100% of SVW result in improved workability and reduction in water demand. The mortars with 20, 40, and 60% SVW resulted in satisfactory mechanical properties, i.e., similar to the control mortar. However, XRD analysis of cement pastes showed that the SVW causes a delay in CH formation, reaching mechanical strength after 28 days. Durability tests results showed that SVW contributes to the mortar becoming more impermeable; therefore, less susceptible to weathering. This study provides an important evaluation of the potential of SVW for application in civil construction, indicating relevant results for replacement of water by liquid wastes in cementitious composites and reduction the use of natural resources.

Dual nanocarrier of chlorhexidine and fluconazole: Physicochemical characterization and effects on microcosm biofilms and oral keratinocytes.

OBJECTIVES: This study assembled and characterized a dual nanocarrier of chlorhexidine (CHX) and fluconazole (FLZ), and evaluated its antibiofilm and cytotoxic effects. METHODS: CHX and FLZ were added to iron oxide nanoparticles (IONPs) previously coated by chitosan (CS) and characterized by physical-chemical analyses. Biofilms from human saliva supplemented with Candida species were grown (72 h) on glass discs and treated (24 h) with IONPs-CS carrying CHX (at 39, 78, or 156 µg/mL) and FLZ (at 156, 312, or 624 µg/mL) in three growing associations. IONPs and CS alone, and 156 µg/mL CHX + 624 µg/mL FLZ (CHX156-FLZ624) were tested as controls. Next, microbiological analyses were performed. The viability of human oral keratinocytes (NOKsi lineage) was also determined (MTT reduction assay). Data were submitted to ANOVA or Kruskal-Wallis, followed by Fisher's LSD or Tukey's tests (α=0.05). RESULTS: Nanocarriers with spherical-like shape and diameter around 6 nm were assembled, without compromising the crystalline property and stability of IONPs. Nanocarrier at the highest concentrations was the most effective in reducing colony-forming units of Streptococcus mutans, Lactobacillus spp., Candida albicans, and Candida glabrata. The other carriers and CHX156-FLZ624 showed similar antibiofilm effects, and significantly reduced lactic acid production (p<0.001). Also, a dose-dependent cytotoxic effect against oral keratinocytes was observed for the dual nanocarrier. IONPs-CS-CHX-FLZ and CHX-FLZ significantly reduced keratinocyte viability at CHX and FLZ concentrations ≥7.8 and 31.25 µg/mL, respectively (p<0.05). CONCLUSION: The nanotherapy developed outperformed the effect of the combination CHX-FLZ on microcosm biofilms, without increasing the cytotoxic effect of the antimicrobials administered. CLINICAL SIGNIFICANCE: The dual nanocarrier is a promising topically-applied therapy for the management of oral candidiasis considering that its higher antibiofilm effects allow the use of lower concentrations of antimicrobials than those found in commercial products.

Chitosan and HPMCAS double-coating as protective systems for alginate microparticles loaded with Ctx(Ile21)-Ha antimicrobial peptide to prevent intestinal infections.

The incorrect use of conventional drugs for both prevention and control of intestinal infections has contributed to a significant spread of bacterial resistance. In this way, studies that promote their replacement are a priority. In the last decade, the use of antimicrobial peptides (AMP), especially Ctx(Ile21)-Ha AMP, has gained strength, demonstrating efficient antimicrobial activity (AA) against pathogens, including multidrug-resistant bacteria. However, gastrointestinal degradation does not allow its direct oral application. In this research, double-coating systems using alginate microparticles loaded with Ctx(Ile21)-Ha peptide were designed, and in vitro release assays simulating the gastrointestinal tract were evaluated. Also, the AA against Salmonella spp. and Escherichia coli was examined. The results showed the physicochemical stability of Ctx(Ile21)-Ha peptide in the system and its potent antimicrobial activity. In addition, the combination of HPMCAS and chitosan as a gastric protection system can be promising for peptide carriers or other low pH-sensitive molecules, adequately released in the intestine. In conclusion, the coated systems employed in this study can improve the formulation of new foods or biopharmaceutical products for specific application against intestinal pathogens in animal production or, possibly, in the near future, in human health.

Conjugation of Ctx(Ile21)-Ha Antimicrobial Peptides to Chitosan Ultrathin Films by N-Acetylcysteine Improves Peptide Physicochemical Properties and Enhances Biological Activity.

The importance of obtaining new compounds with improved antimicrobial activity is a current trend and challenge. Some polymers such as chitosan have shown promising bactericidal properties when they are structurally modified, which is due to the binding versatility provided by their free amines. Likewise, antimicrobial peptides (AMPs) have received attention in recent years because of their bactericidal activity that is similar to or even better than that of conventional drugs, and they exhibit a low induction rate of antimicrobial resistance. Herein, the modified AMP Ctx(Ile21)-Ha-Ahx-Cys was conjugated to chitosan using N-acetylcysteine as an intermediate by the carbodiimide method. Films were prepared using protonated chitosan in 1% acetic acid and Ctx(Ile21)-Ha-Ahx-Cys AMP dissolved in N-acetylcysteine-chitosan; 1.6 mmol of ethylcarbodiimide hydrochloride, 1.2 mmol of N-hydroxysulfosucchimide, and 0.1 mol L -1of N-morpholino)ethanesulfonic acid buffer at pH 6.5 by continuous stirring at 100 × g for 10 min at 37 °C. Physicochemical properties were evaluated by Fourier-transform infrared spectroscopy, differential scanning calorimetry/thermogravimetric analysis, and X-ray diffraction to determine the mechanical properties, solubility, morphology, and thickness. Furthermore, the antimicrobial activities of chitosan-based conjugated films were evaluated againstStaphylococcus aureus,Pseudomonas aeruginosa,SalmonellaTyphimurium, andEscherichia coli. The results showed that the conjugation of a potent AMP could further increase its antibacterial activity and maintain its stable physicochemical properties. Therefore, the developed peptide-chitosan conjugate could be applied as an additive in surgical procedures to prevent and combat bacterial infection.

Alginate-based microparticles coated with HPMCP/AS cellulose-derivatives enable the Ctx(Ile21)-Ha antimicrobial peptide application as a feed additive.

Microencapsulation is a potential biotechnological tool, which can overcome antimicrobial peptides (AMP) instabilities and reduce toxic side effects. Thus, this study evaluates the antibacterial activities of the Ctx(Ile21)-Ha AMP against multidrug-resistant (MDR) and non-resistant bacteria and develop and characterize peptide-loaded microparticles coated with the enteric polymers hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydroxypropylmethylcellulose phthalate (HPMCP). Ctx(Ile21)-Ha was obtained by solid phase peptide synthesis (SPPS) method, purified and characterized by HPLC and Mass Spectrometry. The peptide exhibited potent antibiotic activities against Salmonella enteritidis, Salmonella typhimurium, Pseudomonas aeruginosa (MDR), Acinetobacter baumannii (MDR), and Staphylococcus aureus (MDR). Ctx(Ile21)-Ha microencapsulation was performed by ionic gelation with high efficiency, maintaining the physical-chemical stability. Ctx(Ile21)-Ha coated-microparticles were characterized by DSC, TGA, FTIR-Raman, XRD and SEM. Hemolytic activity assay demonstrated that hemolysis was decreased up to 95% compared to single molecule. In addition, in vitro release control profile simulating different portions of gastrointestinal tract was performed and showed the microcapsules' ability to protect the peptide and release it in the intestine, aiming pathogen's location, mainly by Salmonella sp. Therefore, use of microencapsulated Ctx(Ile21)-Ha can be allowed as an antimicrobial controller in monogastric animal production as an oral feed additive (antimicrobial controller), being a valuable option for molecules with low therapeutic indexes or high hemolytic rates.

Photoluminescent properties in perylene PVD films: Influence of molecular aggregates and supramolecular arrangement.

Organic thin films are at the forefront of basic studies and applications in the field of physics, chemistry, biochemistry and materials science. For example, the intrinsic supramolecular arrangement, or simply the formation of aggregates may alter the optical and electrical properties, which would impact the potential applications of the material. Here, an attempt is made to correlate the molecular structures of two perylene derivatives, bis butylimido perylene (BuPTCD) and bis phenethylimido perylene (PhPTCD), with their film formation, in particular, the supramolecular arrangement and the photoluminescent properties. Emission spectra show that the PhPTCD has a radiative efficiency (RE) higher than that for BuPTCD when both are in solutions (monomers). Complementary, regarding PVD films, UV-Vis absorption measurements reveal that PhPTCD forms, predominantly, J aggregates, which are responsible for perylene derivative emission. However, BuPTCD PVD films are found to provide higher RE than PhPTCD PVD film. This apparent controversy could be explained considering other features such as crystallinity and molecular organization. The PVD film of BuPTCD is crystalline while PhPTCD PVD film is amorphous; BuPTCD has an edge-on while PhPTCD has a face-on molecular organization in PVD films.

Campos elétricos produzidos por equipamentos de diatermia de microondas / Electric fields produced by microwave diathermy equipments

O objetivo deste trabalho foi avaliar os níveis de radiação eletromagnética produzidos por equipamentos de diatermia por microondas, presentes no ambiente de trabalho do fisioterapeuta, e verificar se esses valores são compatíveis com os recomendados pelos organismos nacionais e internacionais. Foram medidos os campos elétricos (E) produzidos por três equipamentos de diatermia por microondas na cidade de Presidente Prudente SP. Foi usado um equipamento marca Wandel & Goltermann, modelo EMR – 200, sonda isotrópica Tipo 8 (de 100 kHz a 3 GHz), para medidas de campo elétrico. Próximo dos aplicadores, de dois dos equipamentos avaliados, os valores medidos estão acima do valor limite (137 V/m) recomendado. Para aplicações no ombro, foram medidos valores de até 650 V/m próximo aos olhos do paciente. Os resultados indicam que existe risco de exposição à doses altas de radiação eletromagnética para os pacientes e para os fisioterapeutas que operam equipamentos de diatermia.

The objective of this study was to evaluate the levels of non-ionizing radiation, produced by microwave diathermy equipments, in the physiotherapists workplaces and check if these values are compatible with the ones adopted by national and international organizations. The electric fields (E) were evaluated around three microwave diathermy equipments in Presidente Prudente SP. To measure the electric fields it was used a Wandel & Goltermann equipment (EMR – 200) with an isotropic probe type 8 (of 100 kHz to 3 GHz). The results show that the electric field is higher than the recommended limit value (137 V/m) near the applicators, to two equipments. During application of microwave on a patient’s shoulder, values were measured up to 650 V/m near the patient’s eyes. The results indicate that there is risk of overexposure to electromagnetic radiation for patients and physiotherapists who work with diathermy equipments.